Align Technology (NASDAQ:ALGN) Downgraded by Wall Street Zen to “Buy”

Wall Street Zen cut shares of Align Technology (NASDAQ:ALGN) from a strong-buy rating to a buy rating in a report issued on Saturday.

ALGN has been the subject of several other research reports. Weiss Ratings upgraded Align Technology from a “hold (c-)” rating to a “hold (c)” rating in a research note on Friday, July 17th. Morgan Stanley raised their price objective on Align Technology from $169.00 to $188.00 and gave the company an “equal weight” rating in a research note on Friday, April 24th. Evercore boosted their target price on Align Technology from $200.00 to $220.00 in a report on Thursday, April 30th. UBS Group reaffirmed a “neutral” rating and set a $189.00 target price on shares of Align Technology in a research report on Thursday, July 23rd. Finally, Citigroup started coverage on Align Technology in a report on Wednesday, April 15th. They set a “buy” rating and a $240.00 price target on the stock. One research analyst has rated the stock with a Strong Buy rating, eight have assigned a Buy rating and six have assigned a Hold rating to the company. According to MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and a consensus price target of $206.36.

Align Technology Trading Down 2.5%

ALGN stock opened at $169.16 on Friday. The firm has a market cap of $12.12 billion, a PE ratio of 29.42, a PEG ratio of 1.73 and a beta of 1.67. Align Technology has a 1 year low of $122.00 and a 1 year high of $200.43. The company has a fifty day simple moving average of $174.55 and a 200 day simple moving average of $175.21.

Align Technology (NASDAQ:ALGN) last posted its earnings results on Wednesday, July 29th. The medical equipment provider reported $2.64 EPS for the quarter, topping the consensus estimate of $2.62 by $0.02. Align Technology had a net margin of 9.99% and a return on equity of 15.86%. The firm had revenue of $1.06 billion for the quarter, compared to the consensus estimate of $1.05 billion. During the same period in the prior year, the business posted $2.49 earnings per share. The business’s quarterly revenue was up 4.3% on a year-over-year basis. As a group, analysts forecast that Align Technology will post 9.48 EPS for the current fiscal year.

Align Technology announced that its Board of Directors has initiated a stock buyback plan on Wednesday, April 29th that allows the company to repurchase $200.00 million in outstanding shares. This repurchase authorization allows the medical equipment provider to purchase up to 1.6% of its shares through open market purchases. Shares repurchase plans are typically an indication that the company’s board believes its stock is undervalued.

Hedge Funds Weigh In On Align Technology

A number of institutional investors have recently made changes to their positions in ALGN. Sequoia Financial Advisors LLC lifted its holdings in shares of Align Technology by 320.1% during the fourth quarter. Sequoia Financial Advisors LLC now owns 7,986 shares of the medical equipment provider’s stock worth $1,247,000 after buying an additional 6,085 shares during the last quarter. Northwestern Mutual Wealth Management Co. boosted its position in shares of Align Technology by 35,513.8% in the fourth quarter. Northwestern Mutual Wealth Management Co. now owns 545,604 shares of the medical equipment provider’s stock valued at $85,196,000 after acquiring an additional 544,072 shares during the period. Capital International Ltd. CA grew its stake in shares of Align Technology by 26.5% in the fourth quarter. Capital International Ltd. CA now owns 57,194 shares of the medical equipment provider’s stock worth $8,931,000 after acquiring an additional 11,977 shares during the last quarter. Lecap Asset Management Ltd. acquired a new stake in shares of Align Technology in the fourth quarter worth $1,814,000. Finally, Merit Financial Group LLC increased its position in Align Technology by 197.3% during the fourth quarter. Merit Financial Group LLC now owns 8,167 shares of the medical equipment provider’s stock worth $1,275,000 after acquiring an additional 5,420 shares during the period. 88.43% of the stock is currently owned by institutional investors.

Align Technology News Roundup

Here are the key news stories impacting Align Technology this week:

• Positive Sentiment: Q2 results exceeded expectations. Align reported adjusted earnings of $2.64 per share and revenue of approximately $1.06 billion, topping consensus estimates. Revenue increased 4.3% year over year, while record Clear Aligner shipments and improved non-GAAP margins supported profitability. Align Technology Q2 Earnings and Revenues Top Estimates
• Positive Sentiment: Digital orthodontics remains a growth focus. Management highlighted expanding digital workflows, connected orthodontic tools and long-term opportunities for Invisalign, iTero scanners and exocad software. The company’s 2026 outlook was reaffirmed, while an orthodontic summit showcased its product and technology strategy. ALGN Q2 Earnings Call Highlights Digital Growth Push
• Positive Sentiment: Board changes could improve shareholder value. Following discussions with Elliott Investment Management, Align plans to add three independent directors and conduct an operational review. The initiatives may increase accountability, improve execution and identify opportunities to enhance returns. Align Technology to Overhaul Board Following Engagement with Elliott
• Neutral Sentiment: Valuation is viewed as more attractive after the pullback. Some analysts see ALGN as reasonably valued, but believe the stock needs faster growth to generate sustained upside. Align Technology: Attractively Valued, But Growth Still Needs To Pick Up
• Negative Sentiment: Near-term guidance and execution remain concerns. Third-quarter revenue guidance of roughly $1.0 billion was described as slightly below or around expectations, limiting the benefit of the earnings beat.
• Negative Sentiment: Systems weakness is capping upside. Analysts noted softer scanner and systems performance, along with pricing pressure, despite strong Clear Aligner volumes. Needham maintained a Hold rating. Align Technology Hold Rating Maintained
• Negative Sentiment: Growth is still relatively modest. Investors may remain cautious because revenue growth has not yet accelerated enough to justify a more bullish outlook, even with improving margins and record aligner shipments.

About Align Technology

Align Technology, Inc (NASDAQ: ALGN) pioneered the use of digital technology in orthodontics through the development of the Invisalign system, a series of clear, removable aligners that provide an alternative to traditional metal braces. Since its founding in 1997 by Zia Chishti and Kelsey Wirth, the Tempe, Arizona–based company has expanded its focus to include intraoral scanners, CAD/CAM software for dental laboratories and comprehensive digital dentistry solutions.

The company’s signature Invisalign system leverages 3D imaging and computer-aided design (CAD) to create customized aligners that gradually reposition teeth, improving patient comfort and treatment predictability.